1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
|
2
|
Loblaw DA, Mendelson DS, Talcott JA, et
al: American Society of Clinical Oncology recommendations for the
initial hormonal management of androgen-sensitive metastatic,
recurrent, or progressive prostate cancer. J Clin Oncol.
22:2927–2941. 2004. View Article : Google Scholar
|
3
|
Feldman BJ and Feldman D: The development
of androgen-independent prostate cancer. Nat Rev Cancer. 1:34–45.
2001. View
Article : Google Scholar : PubMed/NCBI
|
4
|
Hannigan GE, Bayani J, Weksberg R, et al:
Mapping of the gene encoding the integrin-linked kinase, ILK, to
human chromosome 11p15.5-p15.4. Genomics. 42:177–179. 1997.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Hannigan G, Troussard AA and Dedhar S:
Integrin-linked kinase: a cancer therapeutic target unique among
its ILK. Nat Rev Cancer. 5:51–63. 2005. View Article : Google Scholar : PubMed/NCBI
|
6
|
Gil D, Ciolczyk-Wierzbicka D,
Dulinska-Litewka J, Zwawa K, McCubrey JA and Laidler P: The
mechanism of contribution of integrin linked kinase (ILK) to
epithelial-mesenchymal transition (EMT). Adv Enzyme Regul.
51:195–207. 2011. View Article : Google Scholar : PubMed/NCBI
|
7
|
Gao J, Zhu J, Li HY, Pan XY, Jiang R and
Chen JX: Small interfering RNA targeting integrin-linked kinase
inhibited the growth and induced apoptosis in human bladder cancer
cells. Int J Biochem Cell Biol. 43:1294–1304. 2011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Ahmed N, Riley C, Oliva K, Stutt E, Rice
GE and Quinn MA: Integrin-linked kinase expression increases with
ovarian tumour grade and is sustained by peritoneal tumour fluid. J
Pathol. 201:229–237. 2003. View Article : Google Scholar : PubMed/NCBI
|
9
|
Bravou V, Klironomos G, Papadaki E,
Taraviras S and Varakis J: ILK over-expression in human colon
cancer progression correlates with activation of beta-catenin,
down-regulation of E-cadherin and activation of the Akt-FKHR
pathway. J Pathol. 208:91–99. 2006. View Article : Google Scholar : PubMed/NCBI
|
10
|
Intaraprasong P, Assi K, Owen DA, et al:
Expression of integrin-linked kinase is not a useful prognostic
marker in resected hepatocellular cancer. Anticancer Res.
27:4371–4376. 2007.PubMed/NCBI
|
11
|
Goulioumis AK, Bravou V, Varakis J, Goumas
P and Papadaki H: Integrin-linked kinase cytoplasmic and nuclear
expression in laryngeal carcinomas. Virchows Arch. 453:511–519.
2008. View Article : Google Scholar : PubMed/NCBI
|
12
|
Muranyi AL, Dedhar S and Hogge DE:
Targeting integrin linked kinase and FMS-like tyrosine kinase-3 is
cytotoxic to acute myeloid leukemia stem cells but spares normal
progenitors. Leuk Res. 34:1358–1365. 2010. View Article : Google Scholar
|
13
|
Wong RP, Ng P, Dedhar S and Li G: The role
of integrin-linked kinase in melanoma cell migration, invasion, and
tumor growth. Mol Cancer Ther. 6:1692–1700. 2007. View Article : Google Scholar : PubMed/NCBI
|
14
|
Graff JR, Deddens JA, Konicek BW, et al:
Integrin-linked kinase expression increases with prostate tumor
grade. Clin Cancer Res. 7:1987–1991. 2001.PubMed/NCBI
|
15
|
Sasaki T, Ryo A, Uemura H, et al: An
immunohistochemical scoring system of prolyl isomerase Pin1 for
predicting relapse of prostate carcinoma after radical
prostatectomy. Pathol Res Pract. 202:357–364. 2006. View Article : Google Scholar : PubMed/NCBI
|
16
|
Hou Y, Mortimer L and Chadee K: Entamoeba
histolytica cysteine proteinase 5 binds integrin on colonic cells
and stimulates NFkappaB-mediated pro-inflammatory responses. J Biol
Chem. 285:35497–35504. 2010. View Article : Google Scholar : PubMed/NCBI
|
17
|
Buchheit CL, Rayavarapu RR and Schafer ZT:
The regulation of cancer cell death and metabolism by extracellular
matrix attachment. Semin Cell Dev Biol. 23:402–411. 2012.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Lu P, Takai K, Weaver VM and Werb Z:
Extracellular matrix degradation and remodeling in development and
disease. Cold Spring Harb Perspect Biol. 3:a0050582011.PubMed/NCBI
|
19
|
Delcommenne M, Tan C, Gray V, Rue L,
Woodgett J and Dedhar S: Phosphoinositide-3-OH kinase-dependent
regulation of glycogen synthase kinase 3 and protein kinase B/AKT
by the integrin-linked kinase. Proc Natl Acad Sci USA.
95:11211–11216. 1998. View Article : Google Scholar : PubMed/NCBI
|
20
|
Persad S, Attwell S, Gray V, et al:
Inhibition of integrin-linked kinase (ILK) suppresses activation of
protein kinase B/Akt and induces cell cycle arrest and apoptosis of
PTEN-mutant prostate cancer cells. Proc Natl Acad Sci USA.
97:3207–3212. 2000. View Article : Google Scholar : PubMed/NCBI
|
21
|
Troussard AA, McDonald PC, Wederell ED, et
al: Preferential dependence of breast cancer cells versus normal
cells on integrin-linked kinase for protein kinase B/Akt activation
and cell survival. Cancer Res. 66:393–403. 2006. View Article : Google Scholar : PubMed/NCBI
|
22
|
Hers I, Vincent EE and Tavare JM: Akt
signalling in health and disease. Cell Signal. 23:1515–1527. 2011.
View Article : Google Scholar : PubMed/NCBI
|